BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4055050)

  • 1. Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.
    Lode H; Glatzel PD
    Infection; 1985; 13 Suppl 1():S25-7. PubMed ID: 4055050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM; Veldkamp J; Deleers L
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N; van Laethem Y; Vanhoof R; George C; Rapin M; Butzler JP
    Scand J Infect Dis; 1982; 14(1):57-60. PubMed ID: 6280269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of cefotaxime therapy in infections caused by gram-positive pathogens.
    Iannini PB
    Infection; 1985; 13 Suppl 1():S3-6. PubMed ID: 4055052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience of cefotaxime in infections caused by gram-positive pathogens.
    Bassetti D; Solbiati M; Fraizzoli G
    Infection; 1985; 13 Suppl 1():S112-4. PubMed ID: 4055040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.
    Karakusis PH; Trenholme GM; Levin S
    Infection; 1985; 13 Suppl 1():S46-9. PubMed ID: 4055055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
    Barradas P; Zamith M; Videira W; Cardosa T; Marques RA; Avila R
    Chemotherapy; 1989; 35 Suppl 2():33-40. PubMed ID: 2612238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cefotaxime and cefoperazone in respiratory tract infections.
    Garcia-Rodriguez JA; Gomez-Garcia AC
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():301-6. PubMed ID: 6094456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.
    Gomis M; Herranz A; Aparicio P; Filloy JL; Pastor J
    J Antimicrob Chemother; 1990 Sep; 26 Suppl A():45-52. PubMed ID: 2228844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
    Kaneko H; Masaki T; Yamaguchi R; Takahashi N; Umeda M; Shirai T
    Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with cefotaxime in infections caused by gram-positive pathogens, especially Staphylococcus aureus.
    Fujii R
    Infection; 1985; 13 Suppl 1():S9-13. PubMed ID: 4055062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefotaxime (HR-756) in urinary tract infections.
    Paradisi F; Cristiano P; Mirone V; D'Armiento V; Iovene MR
    Chemotherapy; 1982; 28(1):64-9. PubMed ID: 6276110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with cefotaxime in internal medicine between 1981 and 1984.
    Shah PM; Wiesel M; Stille W
    Drugs; 1988; 35 Suppl 2():190-4. PubMed ID: 3135168
    [No Abstract]   [Full Text] [Related]  

  • 17. Ceftriaxone therapy of serious bacterial infections in adults.
    Bittner MJ; Dworzack DL; Preheim LC; Tofte RW; Crossley KB
    Antimicrob Agents Chemother; 1983 Feb; 23(2):261-6. PubMed ID: 6301365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime for the treatment of gram-positive urinary tract infection.
    Piccinno A; Pagliarulo A
    Infection; 1985; 13 Suppl 1():S100-2. PubMed ID: 4055038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment results using cefixime for bacterial respiratory tract infections].
    Leonhardt L
    Infection; 1990; 18 Suppl 3():S115-8. PubMed ID: 2079368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of cefotaxime in pneumology.
    Grassi C; Colombo ML; Peona V
    Acta Med Port; 1983 Feb; 4(2):87-90. PubMed ID: 6303060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.